Threonine synthase-like 1 (S. cerevisiae) (295-305)

Threonine synthase-like 1 (S. cerevisiae) (295-305) is a synthetic peptide fragment corresponding to amino acids 295 through 305 of the threonine synthase-like 1 enzyme from Saccharomyces cerevisiae. As a defined peptide segment derived from a key metabolic enzyme, it serves as a valuable molecular tool for researchers investigating protein structure, function, and interaction dynamics within the context of yeast metabolism and related biochemical pathways. Its sequence specificity and origin from a well-characterized eukaryotic model organism make it particularly relevant for studies in enzymology, metabolic engineering, and the development of peptide-based assays.

Epitope mapping: The peptide's defined sequence enables its use in epitope mapping studies aimed at identifying antibody binding sites within the threonine synthase-like 1 protein. By serving as a representative linear epitope, it facilitates the characterization of immune recognition patterns, supporting the development of specific polyclonal or monoclonal antibodies. This approach is critical for generating high-affinity reagents for immunodetection, immunoprecipitation, or other immunoassay formats targeting the parent protein in yeast or recombinant systems.

Protein-protein interaction studies: As a segment of threonine synthase-like 1, the peptide can be employed to probe protein-protein interactions relevant to metabolic enzyme complexes in S. cerevisiae. Researchers may utilize it in pull-down assays, surface plasmon resonance, or other biophysical methods to assess binding partners and interaction domains. Such studies provide mechanistic insights into the assembly and regulation of metabolic pathways, advancing the understanding of enzyme function and cellular homeostasis.

Enzyme structure-function analysis: The peptide serves as a model substrate or inhibitor in biochemical assays designed to dissect the structure-function relationships of threonine synthase-like 1 and homologous enzymes. By incorporating this fragment in mutagenesis or binding studies, researchers can pinpoint functionally critical residues, elucidate catalytic mechanisms, and assess the effects of sequence variations. These insights are essential for rational protein engineering and the design of targeted metabolic interventions.

Peptide-based assay development: The defined nature of this S. cerevisiae-derived peptide makes it suitable for the development and optimization of peptide-based analytical assays, such as ELISA or mass spectrometry standards. Its use as a calibrator or positive control enhances assay reliability and reproducibility, particularly in workflows aimed at quantifying threonine synthase-like 1 expression or post-translational modifications in yeast-derived samples.

Synthetic peptide research: As a high-purity, well-characterized peptide, this fragment is also valuable for advancing synthetic peptide methodologies, including studies on peptide stability, folding, and aggregation properties. Its application in method development or validation supports broader research into peptide chemistry, solid-phase synthesis protocols, and the design of novel peptide-based biomolecules for biochemical and industrial applications.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L